This product is a novel risk assessment tool for carotid artery stenosis and stroke.  This is a revolutionary healthcare technology using motion analysis and quantification to extract information from pulses for risk assessments.  The entire process is completed by taking a short video clip aimed at the neck with only one simple click on any mobile devices or our apparatus, anywhere, anytime.  In less than five minutes, the user receives an evaluation report indicating low to high stroke risk.
Our product accuracy stands higher than 90% when compared to the clinical outcome.  The future indications of this product can be extended to arrhythmia, venous fistula obstruction, etc.  This product has the great potential to achieve our dream of “personalized mobile hospital” in the future world.

This product is a novel non-invasive and non-contact quick risk assessment tool for carotid artery stenosis and stroke.  This is a revolutionary healthcare technology using motion analysis and quantification to extract information from individual pulses for risk assessments.  The entire process is completed by taking a short video clip aimed at the neck with only one simple click on any mobile device, laptop, or our apparatus, anywhere, anytime.  Our product automatically uploads the video files to our cloud server via internet for calculations.  In less than five minutes, the user receives an evaluation report indicating low to high risk for stroke risk assessments.  The current accuracy of our product stands higher than 90% when compared to the Carotid Duplex Sonography clinical outcome.

In the future, this product could serve as the first screening line prior to Carotid Duplex Sonography at hospital or personal assessment at home.  It is quick, accurate, inexpensive and can be done anywhere, anytime.
We plan to cooperate with major chain pharmacies, clinics, and healthcare centers, putting this product at key locations for providing service to local communities.  We also plan to launch this product to medical institutions, enterprise, insurance companies, etc., and tailor our product to their specific needs.
The future indications of this product can be extended to arrhythmia, venous fistula obstruction, Parkinson disease, etc.  This product has the potential to set the first major cornerstone to achieve the dream of “personalized mobile hospital” in the future world.

Venture capitalist or corporate managers.